Where does ResMed Paris SAS rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ResMed Paris SAS ranks #11,054 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ResMed Paris SAS hold?

ResMed Paris SAS holds 28 US utility patents granted between 2015 and 2025, spanning 14 technology areas.

What is ResMed Paris SAS's Innovation Score?

ResMed Paris SAS has an Innovation Score of 43.7 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is ResMed Paris SAS's patent grant rate increasing or decreasing?

ResMed Paris SAS's recent grant velocity is -7% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for ResMed Paris SAS's patents?

ResMed Paris SAS's patents average 18.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ResMed Paris SAS patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

ResMed Paris SAS

Q: What technology areas does ResMed Paris SAS focus on?

ResMed Paris SAS's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 23 patents, ranking #320 of 3,490 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

USPTO PatentsView assignee record - 28 granted patents across 14 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Resmed ranks #11,054 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 14 technology areas.

#11,054
of 49,997 US assignees by volume: Top 27%
by Innovation Score (43.7/100): 18.9
avg claims per patent: -7%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11054 · Foreign Corporation #11,054 · 28 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 28 grants
UPPER-Q #11,054/49,997
PHOTO-FINISH Radiall
CPC-FOCUS A61M · 14 areas
INNOV-PAR 43.7/100
CLAIMS-RICH 18.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT -7% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Radiall (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Resmed’s 43.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.6 pts (27%) Velocity 7.5 pts (17%) Breadth 13.2 pts (30%) Claim depth 11.3 pts (26%)

Qualcomm Incorporated · highest

85
Koolbridge Solar · near

44
Ortronics · near

44
Vlaamse Instelling… · near

44
Heraeus Electro-Nite… · near

44
ResMed Paris SAS · this assignee

44
3D Lighting… · lowest

7

What this shows Resmed's Innovation Score is 43.7/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Resmed?

Each dot is one of Resmed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Resmed’s own 18.9 claims/patent is ABOVE the 14.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Resmed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Resmed's grants concentrate

ResMed Paris SAS is a focused PatentsView assignee: 14 CPC subclasses with 82.1% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2020. By volume, Resmed sits between Radiall and Rock-Tenn Shared Services, LLC.

Resmed's three-year grant acceleration

ResMed Paris SAS shows 9 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Radiall

28
Raycan Technology…

28
RGB Systems

28
Republic Wireless

28
Revotek

28
Rivada Research

28
Rock River Arms

28
Rock-tenn Shared…

28
Resmed Paris SAS ◀

28

What this shows ResMed holds 28 patents at rank #11,053, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ResMed

By rank, the assignees closest to #11,053 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in ResMed's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for ResMed, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), ResMed ranks #320 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Heraeus Electro-Nite International N.V. 44 Koolbridge Solar, Inc. 44 Ortronics, Inc. 44 Vlaamse Instelling voor Technologisch Onderzoek NV (VITO) 44

Resmed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

ResMed Paris SAS patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	10.7%
2016	2	7.1%
2017	3	10.7%
2018	2	7.1%
2019	4	14.3%
2020	1	3.6%
2021	3	10.7%
2022	4	14.3%
2023	3	10.7%
2024	2	7.1%
2025partial year	1	3.6%

Which technologies does ResMed Paris SAS patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 23

Y02A - Technologies FOR Adaptation TO Climate Change 8

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 3

G05D - Systems FOR Controlling OR Regulating Non-electric Variables 3

H01M - Processes OR Means, e.g. Batteries, FOR THE Direct Conversion OF Chemical Energy Into Electrical Energy 3

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

Y10T - Technical Subjects Covered BY Former US Classification 3

F01N - Gas-flow Silencers OR Exhaust Apparatus FOR Machines OR Engines IN GENERAL; Gas-flow Silencers OR Exhaust Apparatus FOR Internal-combustion Engines 2

A61B - DIAGNOSIS; SURGERY; Identification 1

B01D - Separation 1

F16K - VALVES; TAPS; COCKS; ACTUATING-FLOATS; Devices FOR Venting OR Aerating 1

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; Selection OF Materials FOR Their Magnetic Properties 1

H02K - Dynamo-electric Machines 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ResMed Paris SAS's patent record in context - here's where to go next.

ResMed Paris SAS's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 82.1% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #11,054 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ResMed Paris SAS against Radiall, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.